国际医药卫生导报
國際醫藥衛生導報
국제의약위생도보
INTERNATIONAL MEDICINE & HEALTH GUIDANCE NEWS
2011年
11期
1391-1393
,共3页
谢佐卿%石金秀%刘德忠%姚春花
謝佐卿%石金秀%劉德忠%姚春花
사좌경%석금수%류덕충%요춘화
喜辽妥%静脉炎%效果观察
喜遼妥%靜脈炎%效果觀察
희료타%정맥염%효과관찰
Hirudoid%Phlebitis%Efficacy
目的 探索一种操作简单、疗效显著、医护人员及病人乐于接受的预防和治疗化疗性静脉炎的方法.方法 将使用环磷酰胺、5-氟脲嘧啶、表阿霉素化疗的住院病人随机分为实验组与对照组:实验组40例应用喜辽妥软膏在穿刺处周围并沿血管走向涂抹10~15 cm,每天2次.每次化疗后继续涂抹3天;对照组41例则按传统静脉炎处理方法,用50%硫酸镁湿敷,每天2次,每次化疗后继续涂抹3天.结果 两组病人静脉炎发生率分别为22.50%,67.29%(P<0.05).发生的静脉炎分级比较,疼痛缓解时间和炎症消除时间实验组均低于对照组,差异有显著性(P<0.05).结论 喜辽妥软膏局部涂抹能有效减少环磷酰胺、5-氟脲嘧啶、表阿霉素所致的化学性静脉炎的发生,减轻静脉炎发生的程度,保证了化疗的正常进行,值得推广应用.
目的 探索一種操作簡單、療效顯著、醫護人員及病人樂于接受的預防和治療化療性靜脈炎的方法.方法 將使用環燐酰胺、5-氟脲嘧啶、錶阿黴素化療的住院病人隨機分為實驗組與對照組:實驗組40例應用喜遼妥軟膏在穿刺處週圍併沿血管走嚮塗抹10~15 cm,每天2次.每次化療後繼續塗抹3天;對照組41例則按傳統靜脈炎處理方法,用50%硫痠鎂濕敷,每天2次,每次化療後繼續塗抹3天.結果 兩組病人靜脈炎髮生率分彆為22.50%,67.29%(P<0.05).髮生的靜脈炎分級比較,疼痛緩解時間和炎癥消除時間實驗組均低于對照組,差異有顯著性(P<0.05).結論 喜遼妥軟膏跼部塗抹能有效減少環燐酰胺、5-氟脲嘧啶、錶阿黴素所緻的化學性靜脈炎的髮生,減輕靜脈炎髮生的程度,保證瞭化療的正常進行,值得推廣應用.
목적 탐색일충조작간단、료효현저、의호인원급병인악우접수적예방화치료화료성정맥염적방법.방법 장사용배린선알、5-불뇨밀정、표아매소화료적주원병인수궤분위실험조여대조조:실험조40례응용희료타연고재천자처주위병연혈관주향도말10~15 cm,매천2차.매차화료후계속도말3천;대조조41례칙안전통정맥염처리방법,용50%류산미습부,매천2차,매차화료후계속도말3천.결과 량조병인정맥염발생솔분별위22.50%,67.29%(P<0.05).발생적정맥염분급비교,동통완해시간화염증소제시간실험조균저우대조조,차이유현저성(P<0.05).결론 희료타연고국부도말능유효감소배린선알、5-불뇨밀정、표아매소소치적화학성정맥염적발생,감경정맥염발생적정도,보증료화료적정상진행,치득추엄응용.
Objective To explore a simple, effective therapy in the prevention and treatment of chemotherapy-induced phlebitis which medical staff and patients are all willing to use. Methods 81 patients who received chemotherapy with cyclophosphamide, 5-fluorouracil, and pharmorubicin were randomly divided into two groups:study group ( n = 40 ) and control group ( n = 41 ). In the study group, hirudoid was applied around the puncture point and along the direction of the vessel of 10 - 15cm, twice daily for three days after the start of chemotherapy. The control group received traditional therapy for phlebitis - wet dressing with 50% magnesium sulfate, twice daily for three days. Results The incidence of phlebitis was 22.50% in hirudoid group and 67.29% in magnesium sulfate group ( P< 0.05 ). The time of pain-relief and that of inflammation elimination were shorter in the study group than in the control group ( P < 0.05 ). Conclusions Topical hirudoid can effectively reduce the incidence rate of cyclophosphamide-, 5-fluorouracil-, and pharmorubicin-induced phlebitis, reduce the degree of phlebitis, and ensure the process of chemotherapy. It is worth popularizing.